Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
IBT
IBEX Technologies
C$1.44
C$1.44
C$0.75
C$1.45
C$35.54M-0.0568,888 shs200 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
IBT
IBEX Technologies
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
IBT
IBEX Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
IBT
IBEX Technologies
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
IBT
IBEX Technologies
C$5.77M6.15C$0.92 per share1.56C$0.58 per share2.48
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
IBT
IBEX Technologies
C$3.10MC$0.1211.52N/A53.78%21.95%6.42%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
IBT
IBEX Technologies
N/A3.11%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
IBT
IBEX Technologies
11.06
6.24
4.93

Institutional Ownership

CompanyInstitutional Ownership
IBT
IBEX Technologies
19.05%

Insider Ownership

CompanyInsider Ownership
IBT
IBEX Technologies
25.36%
CompanyEmployeesShares OutstandingFree FloatOptionable
IBT
IBEX Technologies
N/A24.68 millionN/ANot Optionable

Recent News About These Companies

IBT's financial year in review
ibex Launches Wave iX Translate
IBEX Completes Sale of the Company
IBEX Technologies Inc.
Closing Bell: Ibex Technologies Inc flat on Wednesday (IBT)
Closing Bell: Ibex Technologies Inc flat on Thursday (IBT)
Closing Bell: Ibex Technologies Inc down on Thursday (IBT)
Closing Bell: Ibex Technologies Inc up on Tuesday (IBT)
Mayfair Hits 52-Week High on News
IBEX Technologies Inc. (IBT.V)
Closing Bell: Ibex Technologies Inc down on Friday (IBT)

IBEX Technologies CVE:IBT

C$1.44 0.00 (0.00%)
As of 04/5/2024

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.